AI & ML · Aug 15
Weina AI’s Nature Communications paper shows RDPM as multimodal clinical AI for kidney cancer surgery
The Hong Kong based startup’s RDPM model blends 3D imaging and clinical data to support kidney cancer surgery risk decisions.
- Evaluate clinical AI by the decision it supports, not by how impressive the model sounds.
- Multimodal systems can add value when imaging and clinical data answer different parts of one medical question.
- Watch for validation and workflow details before treating any clinical risk score as operationally useful.